EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

NCT06531824 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

11000

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Disease, Chronic

Interventions

DRUG: BI 690517
DRUG: Placebo matching BI 690517
DRUG: Empagliflozin

Sponsor

Boehringer Ingelheim